Abstract
Background sibutramine is a tertiary amine that has been shown to induce dose-dependent weight loss and to enhance the effects of a low-calorie diet for up to a year. We did a randomised, double-blind trial to assess the usefulness of sibutramine in maintaining substantial weight loss over 2 years.
Original language | English |
---|---|
Pages (from-to) | 2119-2125 |
Number of pages | 7 |
Journal | Lancet |
Volume | 23-30 |
Issue number | 356 |
DOIs | |
Publication status | Published - 1 Jan 2000 |